Identification of two pro-VIP forms in a human neuroblastoma cell line.
The immunoreactivity of VIP and PHI standards, immobilized on a nitrocellulose membrane, was first assayed with various detection procedures. For VIP, the double bridge peroxidase-antiperoxidase (PAP) method was the most sensitive procedure, giving a detection limit of 0.1-0.3 pmol per mm2 with the 4 rabbit anti-VIP antisera tested. By contrast, the detection limit of immobilized PHI was 100 times higher with the 4 rabbit anti-PHI/PHM antisera tested presumably because major antigenic sites were masked in the immobilized peptide. With this information at hand, the VIP and PHI immunoreactivity of human neuroblastoma NB-OK-1 cells was tested after extraction, SDS-PAGE, electrotransfer, and PAP immunodetection. Two faint immunoreactive bands corresponding to two pro-VIP forms with an Mr of, respectively, 19 kDa and 18 kDa, were detected in undifferentiated cells. These distinct bands increased progressively and markedly during differentiation in the presence of dibutyryl cyclic AMP. In addition, two intermediary VIP forms of lower Mr (11 kDa and 6 kDa) and 3 kDa VIP itself were also present after 2 days of differentiation. The 19 kDa and 18 kDa pro-VIP forms were detected with a sensitivity several times higher than that of VIP and their staining was specific for VIP epitopes. By contrast, when using 4 rabbit anti-PHI/PHM antisera, we observed essentially the strong unspecific staining of a 17 kDa polypeptide. VIP immunoreactivity was also visualized by immunocytochemistry in neuroblastoma cells cultured on glass coverslips and fixed in situ. Specific VIP staining using the PAP method was present in 10 percent of the cells in the undifferentiated state.(ABSTRACT TRUNCATED AT 250 WORDS)
D003994:Bucladesine; D002460:Cell Line; D006056:Golgi Apparatus / Q000032:analysis; D006651:Histocytochemistry; D006801:Humans; D007120:Immunochemistry; D007124:Immunoenzyme Techniques; D009447:Neuroblastoma / Q000032:analysis*; D010451:Peptide PHI; D010455:Peptides / Q000276:immunology; D011498:Protein Precursors / Q000276:immunology / Q000302:isolation & purification*; D014660:Vasoactive Intestinal Peptide / Q000276:immunology / Q000302:isolation & purification*
D010451:Peptide PHI; D010455:Peptides; D011498:Protein Precursors; D014660:Vasoactive Intestinal Peptide; D003994:Bucladesine